The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Black voters rip Dems over taking them for granted in El-Sayed’s backyard: ‘Hush us up’
Trump-appointed judge blocks blue state’s crackdown on ICE detention center
Breaking: Supreme Court Sides with Trump on White House Ball Room Construction
NY Knicks Owner Turns Against Kathy Hochul, Gives Big to Republican Opponent
ICC president decries being sanctioned by US: ‘Demise of international rule of law’
Appeals court upholds Letitia James subpoena block as DOJ vows to appeal to Supreme Court
Trump to transform spaceflight from spectacle to status quo targeting 3 launches per day
Revealed: The ‘Gentlemen’s Agreement’ That Kept Devastating Karmelo Anthony Evidence Out of Court and What that Evidence Was
Surprise election upset shows hating Trump is no longer enough as Democratic voters turn to new playbook
Surrogate Mom and Baby Flee to TX for Protection as Bio Parents Sue Her for Refusing to Abort Baby
Karmelo Anthony fights for new trial as lawyers clash over unwritten deal that shaped case
Top JPMorganChase exec warns regulatory proposal could squeeze credit for millions of small businesses
AOC blasted as too moderate by Maoist DSA faction as 2028 buzz grows
Trump reaches deal to halt tariffs on beef for 90 days in bid to lower prices
Videos show three suspects in shooting death of Tucson police recruit Carlos Ramirez
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Black voters rip Dems over taking them for granted in El-Sayed’s backyard: ‘Hush us up’
Trump-appointed judge blocks blue state’s crackdown on ICE detention center
Breaking: Supreme Court Sides with Trump on White House Ball Room Construction
NY Knicks Owner Turns Against Kathy Hochul, Gives Big to Republican Opponent
ICC president decries being sanctioned by US: ‘Demise of international rule of law’
Appeals court upholds Letitia James subpoena block as DOJ vows to appeal to Supreme Court
Trump to transform spaceflight from spectacle to status quo targeting 3 launches per day
Revealed: The ‘Gentlemen’s Agreement’ That Kept Devastating Karmelo Anthony Evidence Out of Court and What that Evidence Was
Surprise election upset shows hating Trump is no longer enough as Democratic voters turn to new playbook
Surrogate Mom and Baby Flee to TX for Protection as Bio Parents Sue Her for Refusing to Abort Baby
Karmelo Anthony fights for new trial as lawyers clash over unwritten deal that shaped case
Top JPMorganChase exec warns regulatory proposal could squeeze credit for millions of small businesses
AOC blasted as too moderate by Maoist DSA faction as 2028 buzz grows
Trump reaches deal to halt tariffs on beef for 90 days in bid to lower prices
Videos show three suspects in shooting death of Tucson police recruit Carlos Ramirez
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
